Geographical patterns of Kaposi's sarcoma, nonHodgkin lymphomas, and cervical cancer associated with HIV infection in five African populations

European Journal of Cancer Prevention

Volumn 21, Issue 1, 2012, Pages 1-9

  Chaabna, Karima ^a   Boniol, Mathieu ^b   De Vuyst, Hugo ^a   Vanhems, Philippe ^c,d   De Ávila Vitoria, Marco Antônio ^e   Curado, Maria Paula ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

^d UNIVERSITÉ LYON 1   (France)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Africa; Algeria; Cervical cancer; Egypt; Hepatitis C virus; HIV AIDS; Kaposi's sarcoma; NonHodgkin lymphomas; Tunisia; Uganda; Zimbabwe

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; DISEASE ASSOCIATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; NORTH AFRICA; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; UGANDA; UTERINE CERVIX CANCER; ZIMBABWE;

ADOLESCENT; ADULT; AFRICA; CHILD; CHILD, PRESCHOOL; FEMALE; GEOGRAPHY; HIV; HIV INFECTIONS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PREVALENCE; SARCOMA, KAPOSI; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 82555197920     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32834a802a     Document Type: Article

References (62)

1. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, et al. (2010a). Epidemiology of HIV infection in the Middle East and North Africa. AIDS 24 (Suppl 2):S5-S23.
2. Abu-Raddad LJ, Akala FA, Semini I, Riedner G, Wilson D, Tawil O. (2010b). Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: time for strategic action. Washington, USA: World Bank.
3. Armenian HK, Hoover DR, Rubb S, Metz S, Kaslow R, Visscher B, et al. (1993). Composite risk score for Kaposi's sarcoma based on a case-control and longitudinal study in the Multicenter AIDS Cohort Study (MACS) population. Am J Epidemiol 138:256-265. (Pubitemid 23263596)
4. Banura C, Franceschi S, Doorn LJ, Arslan A, Wabwire-Mangen F, Mbidde EK, et al. (2008). Infection with human papillomavirus and HIV among young women in Kampala, Uganda. J Infect Dis 197:555-562. (Pubitemid 351321533)
5. Ben TN, Zeglaoui F, Ben AT, Ben CT, Fazaa B, Mokhtar I, et al. (2001). Kaposi's sarcoma in Tunisia. Review of 91 cases. Tunis Med 79:429-433.
6. Ben Nejma H (1996). Epidemiology of hepatitis C in Tunisia: results of prospective survey in Ben Aours Governorates - Medical doctoral thesis. Medical Faculty of Tunis, Tunisia.
7. Beral V, Peterman T, Berkelman R, Jaffe H (1991). AIDS-associated non-Hodgkin lymphoma. Lancet 337:805-809.
8. Biggar RJ, Rosenberg PS, Cote T (1996). Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS. Multistate AIDS/Cancer Match Study Group. Int J Cancer 68:754-758. (Pubitemid 27062036)
9. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El GF, et al. (2009). A review of human carcinogens - Part B: biological agents. Lancet Oncol 10: 321-322.
10. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, De SS (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789-1799.
11. Burkitt D, O'Conor GT (1961). Malignant lymphoma in African children. I. A clinical syndrome. Cancer 14:258-269.
12. Cowgill KD, Loffredo CA, Eissa SA, Mokhtar N, Abdel-Hamid M, Fahmy A, et al. (2004). Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol 33:1034-1039. (Pubitemid 39429996)
13. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. (2008). Cancer incidence in five continents. Lyon: IARC.
14. Darwish MA, Faris R, Clemens JD, Rao MR, Edelman R (1996). High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in the Nile Delta: a pilot study. Am J Trop Med Hyg 54:554-558. (Pubitemid 26238822)
15. Dollard SC, Butler LM, Jones AM, Mermin JH, Chidzonga M, Chipato T, et al. (2010). Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the 'Kaposi's sarcoma belt'. Int J Cancer 127:2395-2401.
16. Dos Santos Silva I (1999). Cancer epidemiology: principles and methods. Lyon, France: IARC.
17. El Gaafary MM, Rekacewicz C, Abdel-Rahman AG, Allam MF, El HM, Hamid MA, et al. (2005). Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol 76:520-525. (Pubitemid 40943262)
18. Ezzat S, Bdel-Hamid M, Eissa SA, Mokhtar N, Labib NA, El-Ghorory L, et al. (2005). Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int J Hyg Environ Health 208:329-339. (Pubitemid 41207425)
19. Franceschi S, Rezza G, Serraino D, Cozzi LA, Geddes M, Cote T (1995). Risk for Kaposi's sarcoma among Italian women with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 9:313-314.
20. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891. (Pubitemid 30137669)
21. Fritz A, Pajares JM, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. (2010). International classification of diseases for oncology. Geneva (Switzerland): WHO.
22. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R (2003). Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125:1723-1732. (Pubitemid 37500437)
23. Goedert JJ (2000). The epidemiology of acquired immunodeficiency syndrome malignancies. Semin Oncol 27:390-401. (Pubitemid 30626437)
24. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1996). Human immunodeficiency viruses and human T-cell lymphotropic viruses. Lyon (France): IARC.
25. International Agency for Research on Cancer (IARC) (1997). Kaposi's sarcoma herpesvirus/human herpes virus 8. Lyon (France): IARC.
26. Jang JY, Shao RX, Lin W, Weinberg E, Chung WJ, Tsai WL, et al. (2010). HIV infection increases HCV-induced hepatocyte apoptosis. J Hepatol 54:612-620.
27. Kalter SP, Riggs SA, Cabanillas F, Butler JJ, Hagemeister FB, Mansell PW, et al. (1985). Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males. Blood 66:655-659. (Pubitemid 15230772)
28. Kilani B, Ammari L, Marrakchi C, Letaief A, Chakroun M, Ben JM, et al. (2007). Seroepidemiology of HCV-HIV coinfection in Tunisia. Tunis Med 85: 121-123. (Pubitemid 46761648)
29. Madhava V, Burgess C, Drucker E (2002). Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2:293-302. (Pubitemid 34464740)
30. Mahomva A, Greby S, Dube S, Mugurungi O, Hargrove J, Rosen D, et al. (2006). HIV prevalence and trends from data in Zimbabwe, 1997-2004. Sex Transm Infect 82 (Suppl 1):i42-i47.
31. Marcucci F, Mele A (2011). Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities. Blood 117:1792-1798.
32. Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG (2000). Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 96:2730-2734.
33. Maucort-Boulch D, Franceschi S, Plummer M (2008). International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 17:717-720. (Pubitemid 351469225)
34. Mbah N, Abdulkareem IH, Panti A (2008). AIDS-associated Kaposi's sarcoma in Sokoto, Nigeria. Niger J Clin Pract 11:181-184.
35. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, et al. (2006). Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118:985-990. (Pubitemid 43157675)
36. Middle East Cancer Consortium (MECC) (2010). The Gharbiah Populationbased Cancer Registry (GPCR). Available at: http://www.meccegypt.org/ (25 July 2011).
37. Mougin C, Dalstein V, Pretet JL, Gay C, Schaal JP, Riethmuller D (2001). Epidemiology of cervical papillomavirus infections. Recent knowledge. Presse Med 30:1017-1023. (Pubitemid 32547593)
38. National Cancer Institute (2010). AIDS-related cancers. Available at: http://www.cancer.gov/cancertopics/types/AIDS (25 July 2011).
39. Palefsky J (2009). Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS 4:52-56.
40. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL (1996). Comparability and quality control in cancer registration. Lyon, France: IARC.
41. Parkin DM, Garcia-Giannoli H, Raphael M, Martin A, Katangole-Mbidde E, Wabinga H, et al. (2000). Non-Hodgkin lymphoma in Uganda: a casecontrol study. AIDS 14:2929-2936. (Pubitemid 32042757)
42. Parkin DM, Ferlay J, Hamdi-Chérif M, Sitas F, Thomas JO, Wabinga H, et al. (2003). Cancer in Africa. Lyon, France: IARC.
43. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR (2010). Changing cancer incidence in Kampala, Uganda, 1991-2006. Int J Cancer 126: 1187-1195.
44. Percy C, Van Holten M, Muir C (2010). International classification of diseases for oncology. Geneva: Switzerland.
45. Pfeiffer RM,Wheeler WA, Mbisa G,Whitby D, Goedert JJ, De TG, et al. (2010). Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub- Saharan Africa: clues about etiology. Ann Epidemiol 20:958-963.
46. Polesel J, Franceschi S, Suligoi B, Crocetti E, Falcini F, Guzzinati S, et al. (2010). Cancer incidence in people with AIDS in Italy. Int J Cancer 127:1437-1445.
47. Rabkin CS (1994). Epidemiology of AIDS-related malignancies. Curr Opin Oncol 6:492-496. (Pubitemid 24274013)
48. Ragni MV, Belle SH, Jaffe RA, Duerstein SL, Bass DC, McMillan CW, et al. (1993). Acquired immunodeficiency syndrome-associated non-Hodgkin's lymphomas and other malignancies in patients with hemophilia. Blood 81:1889-1897. (Pubitemid 23101605)
49. Sari Z (2009). Epidemiological and biological caracteristics of hepatitis C in Algeria. Association of Algerian Internist (AILA) 2009. Algiers, Algeria. Available at: http://www.aila-dz.com/uploads/files/sari-hcv-aila-09.pdf.
50. Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, Lemabec T, et al. (2010). The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One 5:e8621.
51. Singal AK, Anand BS (2009). Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review. World J Gastroenterol 15: 3713-3724.
52. Sissolak G, Mayaud P (2005). AIDS-related Kaposi's sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health 10:981-992. (Pubitemid 41445062)
53. Triki H, Said N, Ben SA, Arrouji A, Ben AF, Bouguerra A, et al. (1997). Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91:11-14. (Pubitemid 27095488)
54. UNAIDS, WHO (2008a). Report on the global AIDS epidemic. Geneva; 2010. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/GlobalReport/ 2008/2008-Global-report.asp (1 December 2010).
55. UNAIDS, WHO (2008b). Sub-Saharan Africa AIDS epidemic update regional summary. Geneva; http://data.unaids.org/pub/Report/2008/jc1526-epibriefs- subsaharanafrica-en.pdf (1 December 2010).
56. UNAIDS, WHO (2010a). AIDS epidemic update: December 2002. Geneva; http://www.who.int/hiv/facts/en/epiupdate-en.pdf (1 December 2010).
57. UNAIDS, WHO (2010b). Epidemiological fact sheets on HIV/AIDS and sexually transmitted infectious, 2004 update. Geneva; http://data.unaids.org/ publications/fact-sheets01 (25 July 2010).
58. Wabinga HR, Parkin DM, Wabwire-Mangen F, Mugerwa JW (1993). Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer 54:26-36. (Pubitemid 23136995)
59. WHO (1999). Weekly Epidemiological Record. No 49, 10 December 1999. In. Geneva, Switzerland. Available at: http://www.who.int/docstore/wer/pdf/1999/ wer7449.pdf (25 July 2011).
60. WHO (2010). Progress on global access to HIV antiretroviral therapy: a report on "3 by 5" and beyond. In: Geneva, Switzerland; 2006. Available at: http://www.who.int/hiv/progressreport2006-en.pdf.
61. WHO, ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) (2010). Human Papillomavirus and Related Cancers. Summary Report 2009. Available at: http://www.who.int/hpvcentre (25 July 2010).
62. World Health Organization (WHO), United Nations Population Fund (2010). Preparing for the Introduction of HPV Vaccines: Policy and Programme Guidance for Countries. WHO: Geneva, Switzerland. Available at: http://www.rho.org/files/ WHO-HPV-vac-intro-2006.pdf (21 July 2011).